Today, Quadrant Capital Management LLC Reached $2,608,000 position of UnitedHealth Group Inc. (UNH)

Today, Quadrant Capital Management LLC Reached $2,608,000 position  of UnitedHealth Group Inc. (UNH)
Quadrant Capital Management LLC boosted its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 0.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,630 shares of the healthcare conglomerate’s stock after buying an additional 45 shares during the period. UnitedHealth Group accounts for approximately 2.2% of Quadrant Capital Management LLC’s holdings, making the stock its 14th largest position. Quadrant Capital Management LLC’s holdings in UnitedHealth Group were worth $2,608,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently made changes to their positions in UNH. Toronto Dominion Bank boosted its stake in UnitedHealth Group by 42.1% in the third quarter. Toronto Dominion Bank now owns 74,455 shares of the healthcare conglomerate’s stock worth $10,437,000 after buying an additional 22,052 shares during the last quarter. Appleton Partners Inc. MA boosted its stake in UnitedHealth Group by 8.9% in the third quarter. Appleton Partners Inc. MA now owns 32,143 shares of the healthcare conglomerate’s stock worth $4,500,000 after buying an additional 2,620 shares during the last quarter. KBC Group NV boosted its stake in UnitedHealth Group by 41.7% in the third quarter. KBC Group NV now owns 364,982 shares of the healthcare conglomerate’s stock worth $51,097,000 after buying an additional 107,378 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.9% in the third quarter. Bank of New York Mellon Corp now owns 11,150,584 shares of the healthcare conglomerate’s stock worth $1,561,082,000 after buying an additional 317,180 shares during the last quarter. Finally, Diversified Trust Co boosted its stake in UnitedHealth Group by 0.6% in the third quarter. Diversified Trust Co now owns 3,552 shares of the healthcare conglomerate’s stock worth $497,000 after buying an additional 22 shares during the last quarter. Institutional investors and hedge funds own 86.04% of the company’s stock.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% on Friday, hitting $152.81. The company had a trading volume of 1,664,542 shares. The company has a 50 day moving average price of $142.75 and a 200 day moving average price of $139.46. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $154.50. The firm has a market capitalization of $145.45 billion, a price-to-earnings ratio of 22.57 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The business earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. During the same quarter in the prior year, the company posted $1.77 earnings per share. UnitedHealth Group’s revenue was up 11.6% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be paid a $0.625 dividend. The ex-dividend date is Wednesday, November 30th. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.93%.

A number of research firms recently issued reports on UNH. Credit Suisse Group AG reissued an “outperform” rating and set a $160.00 target price (up from $155.00) on shares of UnitedHealth Group in a research note on Friday, October 21st. Mizuho raised their price target on shares of UnitedHealth Group from $160.00 to $169.00 and gave the stock a “buy” rating in a research note on Wednesday, October 19th. Cowen and Company set a $150.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, September 6th. Leerink Swann set a $175.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Wednesday, October 19th. Finally, Evercore ISI started coverage on shares of UnitedHealth Group in a research note on Thursday, September 22nd. They set a “buy” rating and a $155.00 price target for the company. Two research analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $158.03.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,460 shares of the company’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total value of $822,003.00. Following the completion of the transaction, the director now owns 60,052 shares of the company’s stock, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. 1.65% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Related posts

Leave a Comment